A

Alnylam Pharmaceuticals

2097 employees

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
RNAi
Health Care
Biotech
Therapeutics
Medical
Rare Diseases
Pharmaceutical
Drug Development
Biopharma
Pharmaceuticals

Date founded

2002

Funding rounds raised

Total raised

$800M

from 8 investors over 8 rounds

A

Alnylam Pharmaceuticals raised $750M on April 13, 2020

Investors: GSO Capital Partners

A

Alnylam Pharmaceuticals raised $800M on April 8, 2019

Investors: Regeneron

A

Alnylam Pharmaceuticals raised $700M on January 13, 2014

Investors: Genzyme

A

Alnylam Pharmaceuticals raised $25M on July 7, 2003

Investors: Atlas Venture, Abingworth, Cardinal Partners (CP), Polaris Partners and ARCH Venture Partners

FAQ